project id: TCGA-ACC; case submitter id: TCGA-OR-A5L3; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.86; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.07; rna integrity number: 8.2; age at index: 67; days to birth: -24763; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1933; age at diagnosis: 24763; ajcc clinical m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage I; ajcc pathologic t: T1; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 4628.0; icd 10 code: C74.0; last known disease status: not reported; morphology: 8370/3; primary diagnosis: Adrenal cortical carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cortex of adrenal gland; synchronous malignancy: No; tissue or organ of origin: Cortex of adrenal gland; tumor grade: Not Reported; year of diagnosis: 2000; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 4591; initial weight: 70.0; sample id: fc7aa029-f103-41fb-add3-dd6070a13daf; sample submitter id: TCGA-OR-A5L3-01A; portion id: 465d1563-4c2a-4ab0-a974-dcdbdb8b0099; portion submitter id: TCGA-OR-A5L3-01A-11; slide id: 7b47e24d-c744-4a83-ab44-88779b144a6b; slide submitter id: TCGA-OR-A5L3-01A-01-TS1; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 15.0; percent tumor cells: 85.0; percent tumor nuclei: 90.0; section location: TOP;